1-3 of 3
Ilaria Turin
Close
Sort by
Journal Articles

Evaluation of Interaction Between NK Cells and Colorectal Carcinoma Cells for Development of NK Cell-Based Immunotherapy in Patients with Refractory Disease

Elisabetta Todisco, MD, Ilaria Turin, Federica Ferulli, Matteo Tanzi, Silvia Brugnatelli, Sara Delfanti, Marcello Maestri, Matteo Donadon, Matteo Cimino, Guido Torzilli, Armando Santoro, MD, Paolo Pedrazzoli, Daniela Montagna
Journal: Blood
Blood (2014) 124 (21): 5810.
https://doi.org/10.1182/blood.V124.21.5810.5810
Published: 2014
Journal Articles

In Vitro Preclinical Study Results for a Phase I Adoptive Immunotherapy Trial Using Cetuximab in Association with Allogeneic NK Cell Infusion in KRAS Oncogene Mutated Metastatic Colorectal Cancer Patients.

Elisabetta Todisco, Francesca Re, Donatella Genovese, Ilaria Turin, Lorenza Rimassa, Adalberto Ibatici, Luca Castagna, Armando Santoro, Daniela Montagna
Journal: Blood
Blood (2009) 114 (22): 5119.
https://doi.org/10.1182/blood.V114.22.5119.5119
Published: 2009
Journal Articles

Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia

Daniela Montagna, Rita Maccario, Franco Locatelli, Enrica Montini, Sara Pagani, Federico Bonetti, Liane Daudt, Ilaria Turin, Daniela Lisini, Claudio Garavaglia, Paolo Dellabona, Giulia Casorati
Journal: Blood
Blood (2006) 108 (12): 3843–3850.
https://doi.org/10.1182/blood-2006-05-021535
Published: 2006